MDK-6983

CAS No. 1227476-98-3

MDK-6983( Autophagy inhibitor 6k | Compound 6k | MDK-6983 | MDK 6983 | MDK6983 )

Catalog No. M27899 CAS No. 1227476-98-3

MDK-6983 is an inhibitor of autophagy and disrupts the dynamics of actin cytoskeleton in human melanoma cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 283 In Stock
5MG 249 In Stock
10MG 368 In Stock
25MG 562 In Stock
50MG 770 In Stock
100MG 1032 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MDK-6983
  • Note
    Research use only, not for human use.
  • Brief Description
    MDK-6983 is an inhibitor of autophagy and disrupts the dynamics of actin cytoskeleton in human melanoma cells.
  • Description
    MDK-6983 is an inhibitor of autophagy and disrupts the dynamics of actin cytoskeleton in human melanoma cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Autophagy inhibitor 6k | Compound 6k | MDK-6983 | MDK 6983 | MDK6983
  • Pathway
    Autophagy
  • Target
    Autophagy
  • Recptor
    microtubule
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1227476-98-3
  • Formula Weight
    429.3
  • Molecular Formula
    C22H18Cl2N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Oc1ccc(Cl)cc1C(=O)N[C@H](Cc1ccccc1)C(=O)Nc1ccc(Cl)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wood AC, et al. Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program. Pediatr Blood Cancer. 2013;60(11):1860-1867.
molnova catalog
related products
  • Sulfacetamide sodium

    Sulfacetamide Sodium is an anti-infective agent that is used topically to treat skin infections and orally for urinary tract infections.

  • AGN 196996

    AGN 196996 is a potent and selective inhibitor of RARα (Ki: 2 nM), exhibiting very low affinity for RARβ (Ki: 1087 nM) and RARγ (Ki: 8523 nM).

  • AUTEN-67

    A small molecule autophagy enhancer that specificly inhibits myotubularin-related phosphatase MTMR14; at concentrations of 2, 10, and 100 uM, AUTEN-67 inhibits MTMR14 by nearly 3%, 25%, and 70%, respectively.